266 related articles for article (PubMed ID: 16157118)
1. The cost effectiveness of empiric intravenous immunoglobulin for the antepartum treatment of fetal and neonatal alloimmune thrombocytopenia.
Thung SF; Grobman WA
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1094-9. PubMed ID: 16157118
[TBL] [Abstract][Full Text] [Related]
2. [Is a non-invasive management allowed for maternofetal alloimmune thrombocytopenia? Experience over a 10-year period].
Deruelle P; Wibaut B; Manessier L; Subtil D; Vaast P; Puech F; Valat AS
Gynecol Obstet Fertil; 2007 Mar; 35(3):199-204. PubMed ID: 17306591
[TBL] [Abstract][Full Text] [Related]
3. Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial.
Berkowitz RL; Lesser ML; McFarland JG; Wissert M; Primiani A; Hung C; Bussel JB
Obstet Gynecol; 2007 Aug; 110(2 Pt 1):249-55. PubMed ID: 17666597
[TBL] [Abstract][Full Text] [Related]
4. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia.
Berkowitz RL; Kolb EA; McFarland JG; Wissert M; Primani A; Lesser M; Bussel JB
Obstet Gynecol; 2006 Jan; 107(1):91-6. PubMed ID: 16394045
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulins without initial and follow-up cordocentesis in alloimmune fetal and neonatal thrombocytopenia at high risk for intracranial hemorrhage.
Kanhai HH; van den Akker ES; Walther FJ; Brand A
Fetal Diagn Ther; 2006; 21(1):55-60. PubMed ID: 16354976
[TBL] [Abstract][Full Text] [Related]
6. Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia.
Lakkaraja M; Berkowitz RL; Vinograd CA; Manotas KC; Jin JC; Ferd P; Gabor J; Wissert M; McFarland JG; Bussel JB
Am J Obstet Gynecol; 2016 Oct; 215(4):471.e1-9. PubMed ID: 27131591
[TBL] [Abstract][Full Text] [Related]
7. A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia.
Radder CM; Brand A; Kanhai HH
Am J Obstet Gynecol; 2001 Sep; 185(3):683-8. PubMed ID: 11568798
[TBL] [Abstract][Full Text] [Related]
8. Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group.
Durand-Zaleski I; Schlegel N; Blum-Boisgard C; Uzan S; Dreyfus M; Kaplan C
Am J Perinatol; 1996 Oct; 13(7):423-31. PubMed ID: 8960612
[TBL] [Abstract][Full Text] [Related]
9. Neonatal alloimmune thrombocytopenia: antenatal management.
Silver RM; Porter TF; Branch DW; Esplin MS; Scott JR
Am J Obstet Gynecol; 2000 May; 182(5):1233-8. PubMed ID: 10819864
[TBL] [Abstract][Full Text] [Related]
10. Chronic villitis in untreated neonatal alloimmune thrombocytopenia: an etiology for severe early intrauterine growth restriction and the effect of intravenous immunoglobulin therapy.
Althaus J; Weir EG; Askin F; Kickler TS; Blakemore K
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1100-4. PubMed ID: 16157119
[TBL] [Abstract][Full Text] [Related]
11. Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura.
Xie F; Blackhouse G; Assasi N; Campbell K; Levin M; Bowen J; Tarride JE; Pi D; Goeree R
Clin Ther; 2009 May; 31(5):1082-91; discussion 1066-8. PubMed ID: 19539109
[TBL] [Abstract][Full Text] [Related]
12. Antenatal treatment of neonatal alloimmune thrombocytopenia.
Bussel JB; Berkowitz RL; McFarland JG; Lynch L; Chitkara U
N Engl J Med; 1988 Nov; 319(21):1374-8. PubMed ID: 3141811
[TBL] [Abstract][Full Text] [Related]
13. Antenatal treatment of alloimmune thrombocytopenia.
Lynch L; Bussel JB; McFarland JG; Chitkara U; Berkowitz RL
Obstet Gynecol; 1992 Jul; 80(1):67-71. PubMed ID: 1603500
[TBL] [Abstract][Full Text] [Related]
14. Follow up of children after antenatal treatment for alloimmune thrombocytopenia.
Radder CM; de Haan MJ; Brand A; Stoelhorst GM; Veen S; Kanhai HH
Early Hum Dev; 2004 Oct; 80(1):65-76. PubMed ID: 15363839
[TBL] [Abstract][Full Text] [Related]
15. The management of alloimmune neonatal thrombocytopenia.
Blanchette VS; Johnson J; Rand M
Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):365-90. PubMed ID: 11030040
[TBL] [Abstract][Full Text] [Related]
16. [Prenatal management of fetuses with alloimmune thrombocytopenia].
Kroll H; Kiefel V; Giers G; Kaplan C; Murphy M; Waters A; Mueller-Eckhardt C
Beitr Infusionsther Transfusionsmed; 1996; 33():150-5. PubMed ID: 8974688
[TBL] [Abstract][Full Text] [Related]
17. The management of feto-maternal alloimmune thrombocytopenia: report of three cases.
Paternoster DM; Cester M; Memmo A; Scandellari R; Fabris F; Girolami A
J Matern Fetal Neonatal Med; 2006 Aug; 19(8):517-20. PubMed ID: 16966118
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of antenatal screening for neonatal alloimmune thrombocytopenia.
Killie MK; Kjeldsen-Kragh J; Husebekk A; Skogen B; Olsen JA; Kristiansen IS
BJOG; 2007 May; 114(5):588-95. PubMed ID: 17355359
[TBL] [Abstract][Full Text] [Related]
19. A review of the contemporary management of fetal and neonatal alloimmune thrombocytopenia in an Australian tertiary obstetric hospital.
Cook TJ; Qiu CC; Dickinson JE
Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):321-6. PubMed ID: 22510050
[TBL] [Abstract][Full Text] [Related]
20. [Intravenous human immunoglobulin treatment for neonatal alloimmune thrombocytopenia due to anti-HPA-5b with severe previous history].
Moncharmont P; Vignal M; Merieux Y; Rigal D
Arch Pediatr; 2007 Sep; 14(9):1094-6. PubMed ID: 17590318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
